Videos / Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes
Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes
Description
In this Product Explainer, Endocrinologist Prof Richard O’Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Expert panel – A/Prof Samantha Hocking & Dr Terri-Lynne South, facilitated by A/Prof Ralph Audehm
GLP 1s & Sarcopenia: Fact vs Hype
Dr Deb Mills
The New Dengue Vaccine – What You Need to Know
Dr Robert Hungerford
Hypertriglyceridaemia – Causes, Assessment & Management of CV Risk
A/Prof Michelle Rodrigues
Management of Photoageing
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
Endocrinologist; Clinical Dean of Medicine, University of Melbourne, Austin Clinical School; Director of Graduate Programs, Melbourne Medical School; Senior Endocrinologist and Director, Lipid Service, Austin Health
